Resitu: minimally invasive surgical technology

Gustav Notander

Gustav has a MSc.Eng. in Biotechnology from KTH Royal Institute of Technology in Stockholm. He is currently working as Investment Manager at Almi Invest Stockholm, and in addition to Resitu, is a member of the board in Developeration AB, and Medituner AB. He has previously worked 15+ years as a business development coach and technology transfer manager at KTH Innovation, and as IP Manager at KTH Holding AB.

Published 2022-06-07


Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.